Country: United States
Language: English
Source: NLM (National Library of Medicine)
DOCONEXENT (UNII: ZAD9OKH9JC) (DOCONEXENT - UNII:ZAD9OKH9JC), ICOSAPENT (UNII: AAN7QOV9EA) (ICOSAPENT - UNII:AAN7QOV9EA), CALCIUM (UNII: SY7Q814VUP) (CALCIUM - UNII:SY7Q814VUP), IRON (UNII: E1UOL152H7) (IRON - UNII:E1UOL152H7), ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R), PYRIDOXINE (UNII: KV2JZ1BI6Z) (PYRIDOXINE - UNII:KV2JZ1BI6Z), .ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1) (.ALPHA.-TOCOPHEROL - UNII:H4N855PNZ1), FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8)
MEDA Pharmaceuticals
DOCONEXENT
DOCONEXENT 250 mg
ORAL
PRESCRIPTION DRUG
Natelle® One is indicated to provide vitamin/mineral and DHA omega–3 fatty acid supplementation to women throughout pregnancy, during the postnatal period for both lactating and non–lactating mothers, and throughout the childbearing years. Natelle® One may be beneficial in improving the nutritional status of women prior to conception. This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Supplied in child resistant bottles of 30 capsules (NDC 0037-6072-30). Store at controlled room temperature 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F). KEEP THIS AND ALL DRUGS/MEDICATIONS OUT OF THE REACH OF CHILDREN.
unapproved drug other
NATELLE ONE- DOCONEXENT, ICOSAPENT, CALCIUM, IRON, ASCORBIC ACID, PYRIDOXINE, .ALPHA.- TOCOPHEROL, FOLIC ACID CAPSULE, GELATIN COATED MEDA PHARMACEUTICALS _Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been_ _approved by FDA. For further information about unapproved drugs, click here._ ---------- NATELLE ONE Rx Prenatal Vitamin & Plant-Based DHA. Now with 28 mg iron BOXED WARNING WARNING: ACCIDENTAL OVERDOSE OF IRON-CONTAINING PRODUCTS IS A LEADING CAUSE OF FATAL POISONING IN CHILDREN UNDER 6 YEARS OF AGE. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. IN CASE OF ACCIDENTAL OVERDOSE, CALL A DOCTOR OR POISON CONTROL CENTER IMMEDIATELY. DESCRIPTION Natelle® One capsules for oral administration are supplied as oblong red soft gelatin capsules, imprinted with "Natelle1" in white ink. EACH CAPSULE CONTAINS: Docosahexaenoic Acid (DHA) from Algal Oil..................................250 mg Eicosapentaenoic Acid (EPA).................................Not more than 0.625mg Calcium (Tricalcium Phosphate).......................................................102 mg Iron (Ferrous Fumarate) ...................................................................28 mg Vitamin C (Ascorbic Acid) ...............................................................30 mg Vitamin B-6 (Pyridoxine HCl) ...........................................................25 mg Vitamin E (D-Alpha Tocopherol) ......................................................30 IU Folic Acid ..........................................................................................1 mg DHA is an omega-3 fatty acid. 250 mg of DHA from 625 mg of algal oil is derived from Crypthecodinium cohnii. DHA is derived from the oils of microalgae, which is grown outside of the ocean, in a controlled environment, eliminating the risk of oceanic contamination. INACTIVE INGREDIENTS: Gelatin (Bovine), Beeswax, Glycerine, Soybean Oil, Lecithin, Titanium Dioxide, Ethyl Vanillin. INDICATIONS AND USAGE Natelle® One is indicated to prov Read the complete document